Table 3.
Group | N | GMT1 (95% CI) (mIU/mL) | F# | P | N | GMT2 (95% CI) (mIU/mL) | F# | P |
---|---|---|---|---|---|---|---|---|
Group I | 241 | 51.29 (38.02–67.61) | 55.26 | <0.001 | 104 | 22.91 (14.45–36.31) | 3.61 | 0.029 |
Group II | 290 | 165.96 (125.89–218.78)a | 45 | 16.98 (8.51–33.88) | ||||
Group III | 240 | 478.63 (354.81–630.96)ab | 93 | 8.91 (5.25–15.49)a |
N, Total number; GMT, the geometric mean titer of anti-HBs; GMT 1, GMT 1 month later; GMT 2, GMT 8 years later.
#The one-way analysis of variance was used to compare the GMT among the three groups and the leastsignificant difference (LSD) was used for multiple comparisons.
aP < 0.05, compared with Group I.
bP < 0.05, compared with Group II